Logo image of GMAB

GENMAB A/S -SP ADR (GMAB) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:GMAB - US3723032062 - ADR

33.42 USD
-0.3 (-0.89%)
Last: 12/26/2025, 8:00:00 PM
33.42 USD
0 (0%)
After Hours: 12/26/2025, 8:00:00 PM
Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to GMAB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 135.67. This target is 305.95% above the current price.
GMAB was analyzed by 27 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about GMAB.
In the previous month the buy percentage consensus was at a similar level.
GMAB was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
GMAB Historical Analyst RatingsGMAB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -108 -98 -88 -78 -68 -58 -48 -38 -28 -18 -8 10 20 30

Price Target & Forecast

Price Low Median Mean High 33.4221.08126.01135.67263.69 - -36.92% 277.04% 305.95% 689.02%
GMAB Current Analyst RatingGMAB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-11-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-11-07 Truist Securities Reiterate Buy -> Buy
2025-10-15 HC Wainwright & Co. Reiterate Buy -> Buy
2025-10-02 HC Wainwright & Co. Maintains Buy -> Buy
2025-09-24 Guggenheim Upgrade Neutral -> Buy
2025-09-23 Guggenheim Upgrade Neutral -> Buy
2025-08-15 HC Wainwright & Co. Maintains Buy -> Buy
2025-07-08 Truist Securities Maintains Buy -> Buy
2025-04-09 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-11 William Blair Upgrade Market Perform -> Outperform
2025-03-11 Truist Securities Maintains Buy -> Buy
2025-02-13 Leerink Partners Upgrade Market Perform -> Outperform
2025-01-23 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-22 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-08 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-08 BMO Capital Reiterate Outperform -> Outperform
2024-10-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-11 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-09-09 Truist Securities Maintains Buy -> Buy
2024-09-04 Morgan Stanley Reiterate Equal-Weight
2024-08-27 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-20 JP Morgan Downgrade Overweight -> Neutral
2024-08-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-18 HC Wainwright & Co. Reiterate Buy -> Buy

GENMAB A/S -SP ADR / GMAB FAQ

What is the average price target for GENMAB A/S -SP ADR (GMAB) stock?

27 analysts have analysed GMAB and the average price target is 41.78 USD. This implies a price increase of 25.01% is expected in the next year compared to the current price of 33.42.


What is the consensus rating for GENMAB A/S -SP ADR (GMAB) stock?

The consensus rating for GENMAB A/S -SP ADR (GMAB) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for GMAB stock?

The number of analysts covering GENMAB A/S -SP ADR (GMAB) is 27.